Cell line · CVCL_5239
1205Lu
Cancer cell line, Homo sapiens. Cutaneous melanoma. Cellosaurus records it as partially contaminated. 21 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. 1205Lu. Cell lines, record CVCL_5239. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_5239
On this page
Cell line
As Cellosaurus gives it.
- Name
- 1205Lu
- Accession
- CVCL_5239
- RRID
- RRID:CVCL_5239
- Synonyms
- 1205-Lu, 1205 Lu, WM 1205LU, WM-1205LU, WM1205Lu, WM1205, LU1205, Lu1205, WC00058
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 37Y
- Category
- Cancer cell line
- Diseases
- Cutaneous melanoma (NCIt C3510)
- Derived from
- Skin (in situ)
- Parent
- WM793 (CVCL_8787)
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems2
| Problem | Cellosaurus's note |
|---|---|
| Partially contaminated | The stock formerly distributed by Coriell (WC00058) contains a significant amount of mouse DNA (DOI=10.4172/1948-5956.1000196). This is not the case of the original Wistar stock which was distributed by Rockland (DOI=10.4172/1948-5956.1000401). |
| Caution | The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: Amelogenin: X,Y->X, D16S539: 11,12->10,12, D7S820: 10,12->10, D8S1179: 11,12,14->12,14 and vWA: 16,17->17. |
Source Cellosaurus
Papers21
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway. | Oncogenesis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| FRA1 drives melanoma metastasis through an actionable transcriptional network. | Oncogene | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The IFNγ-CIITA-MHC II axis modulates melanoma cell susceptibility to NK-cell-mediated cytotoxicity. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| FRA1 drives melanoma metastasis through an actionable transcriptional network. | bioRxiv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| PHGDH Induction by MAPK Is Essential for Melanoma Formation and Creates an Actionable Metabolic Vulnerability. | Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy. | Cell | 2024 | Its Methods give the RRID and name the line | PubMed | |
| p300 KAT Regulates SOX10 Stability and Function in Human Melanoma. | Cancer Res Commun | 2024 | Its Methods give the RRID and name the line | PubMed | |
| HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression. | NAR Cancer | 2024 | Its Methods give the RRID and name the line | PubMed | |
| PTEN Lipid Phosphatase Activity Suppresses Melanoma Formation by Opposing an AKT/mTOR/FRA1 Signaling Axis. | Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 21
See all 21 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Parent | WM793 | CVCL_8787 |
Source Cell lines
Cell banks3
| Cell bank | Catalog number | Status |
|---|---|---|
| ATCC | CRL-2812 | Discontinued |
| Coriell | WC00058 | Discontinued |
| Rockland | 51603 | Discontinued |
Source Cellosaurus
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_5239
GET https://conductscience.org/api/cell-lines/v1/CVCL_5239/papers?page=2